This is a single-center, not-randomized, open-label, controlled pilot clinical trial. This study compares presence of Trauma Induced Coagulopathy (TIC) and acute traumatic hemorrhage treatment at pre-hospital phase of care with red blood cells (RBC), Tranexamic acid (TXA) and Fibrinogen Concentrate (FC) with the current treatment based on the administration of Crystalloids and TXA.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
TEG6s(R) parameters for Trauma Induced Coagulopathy (TIC)
Timeframe: Basal (at the crash site)
TEG6s(R) parameters for Trauma Induced Coagulopathy (TIC)
Timeframe: Basal (at the hospital arrival)
All-cause mortality
Timeframe: 1 hour post hospital admission
All-cause mortality
Timeframe: 6 hours post hospital admission
All-cause mortality
Timeframe: 24 hours post hospital admission
Accountability
Timeframe: 30 days
Temperature storage conditions of the red blood cells concentrate
Timeframe: 24 hours